Coherent's (COHR) price-to-earnings ratio stands at 77.6, a multiple that requires the company's profits to grow approximately 3.6 times from current levels to match the S&P 500's valuation of 21.4. Management stated on the fiscal Q4 2026 earnings call that the company is booked out for fiscal 2027, driven by orders from AI data center customers. This strong demand has propelled Coherent stock up 196% over the past twelve months, significantly outpacing the S&P 500's 16.0% gain over the same period.
The valuation gap reflects a market pricing in future earnings rather than current performance. Over the past twelve months, Coherent generated $0.8 billion in net profit on revenue of $7.1 billion, resulting in a net margin of 11.3%. This margin is lower than the 13.1% average for the S&P 500, indicating that investors are paying a premium for anticipated growth rather than existing profitability.
| Metric | Coherent | S&P 500 |
|---|---|---|
| P/E Ratio | 77.6 | 21.4 |
| Net Margin | 11.3% | 13.1% |
| 12-Month Return | 196% | 16.0% |
Coherent's revenue growth is currently constrained by production capacity rather than demand. The company reported record revenue of $2.05 billion in fiscal Q4 2026, a 34% increase year-over-year. Management attributed this rise to demand from AI data centers and communications customers. However, the primary constraint on further sales growth is indium phosphide capacity, which Coherent manufactures in-house.
Management indicated that the company is on track to double its indium phosphide output capacity by the end of fiscal Q1 2027, a timeline one quarter ahead of its original plan. Long-term customer agreements include minimum demand guarantees, ensuring a baseline of orders through calendar 2027.
Looking ahead, management guided fiscal Q1 2027 revenue to between $2.2 billion and $2.4 billion, up from the previous quarter's $2.05 billion. Results for this quarter are pending. The company also expects quarterly revenue to exceed $3 billion for the first time by the end of fiscal 2027. If production capacity fails to expand as planned, booked orders will ship later, delaying the arrival of the profits currently embedded in the stock's valuation.
The upcoming fiscal Q1 2027 report will provide critical validation of this build-out. Revenue at or above the guided range, combined with doubled indium phosphide capacity, would suggest Coherent is on schedule. Conversely, revenue below $2.2 billion would signal that capacity is lagging behind orders, pushing out the realization of future earnings.